本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aerovate Therapeutics, Inc.

9.80
0.0000
成交量:- -
成交額:276.85萬
市值:2.84億
市盈率:-5.76
高:9.80
開:9.80
低:9.80
收:9.80
52周最高:884.98
52周最低:9.80
股本:2,898.50萬
流通股本:1,196.45萬
量比:- -
換手率:- -
股息:2.40
股息率:24.49%
每股收益(TTM):-1.7025
每股收益(LYR):-2.4361
淨資產收益率:-59.01%
總資產收益率:-36.18%
市淨率:3.79
市盈率(LYR):-4.02

資料載入中...

2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities